Eversept Partners, LP Infla Rx N.V. Transaction History

Eversept Partners, LP

$904 Million
Q1 2025

A detailed history of Eversept Partners, LP transactions in Infla Rx N.V. stock. As of the latest transaction made, Eversept Partners, LP holds 1,675,978 shares of IFRX stock, worth $1.36 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,675,978

Previous 492,452 240.33%

Holding current value

$1.36 Million

Previous $1.23 Million 39.4%

% of portfolio

0.19%

Previous 0.12%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.02 - $2.62 $1.21 Million - $3.1 Million	1,183,526 Added 240.33%	1,675,978 $1.71 Million
Q4 2024 Feb 14, 2025	SELL	$1.38 - $2.64 $1.56 Million - $2.98 Million	-1,129,335 Reduced 69.64%	492,452 $1.23 Million
Q3 2024 Nov 14, 2024	BUY	$1.34 - $1.73 $73,508 - $94,902	54,857 Added 3.5%	1,621,787 $2.48 Million
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.74 $308,912 - $455,514	261,790 Added 20.06%	1,566,930 $2.73 Million
Q4 2023 Feb 14, 2024	SELL	$1.25 - $2.75 $540,505 - $1.19 Million	-432,404 Reduced 24.89%	1,305,140 $2.13 Million
Q3 2023 Nov 14, 2023	SELL	$2.66 - $4.33 $472,333 - $768,873	-177,569 Reduced 9.27%	1,737,544 $5.18 Million
Q2 2023 Aug 14, 2023	BUY	$2.05 - $6.1 $3.93 Million - $11.7 Million	1,915,113 New	1,915,113 $8.54 Million
Q2 2021 Aug 16, 2021	SELL	$2.72 - $4.04 $730,684 - $1.09 Million	-268,634 Closed	0 $0
Q1 2021 Nov 08, 2023	SELL	$3.62 - $6.34 $5.96 Million - $10.4 Million	-1,646,479 Reduced 85.97%	268,634 $1.05 Million
Q1 2021 May 13, 2021	BUY	$3.62 - $6.34 $972,455 - $1.7 Million	268,634 New	268,634 $1.05 Million
Q2 2020 Aug 13, 2020	SELL	$4.59 - $8.96 $897,289 - $1.75 Million	-195,488 Closed	0 $0
Q1 2020 Nov 08, 2023	SELL	$2.65 - $6.08 $368,694 - $845,910	-139,130 Reduced 41.58%	195,488 $746,000
Q1 2020 May 13, 2020	SELL	$2.65 - $6.08 $368,694 - $845,910	-139,130 Reduced 41.58%	195,488 $747,000
Q4 2019 Nov 08, 2023	SELL	$2.2 - $4.54 $3.48 Million - $7.18 Million	-1,580,495 Reduced 82.53%	334,618 $1.33 Million
Q4 2019 Feb 13, 2020	BUY	$2.2 - $4.54 $736,159 - $1.52 Million	334,618 New	334,618 $1.33 Million

Others Institutions Holding IFRX

# of Institutions

Shares Held

18.3M

Call Options Held

33.6K

Put Options Held

2.2K

View Full List

About InflaRx N.V.

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $35.8M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

More about IFRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account

Eversept Partners, LP Infla Rx N.V. Transaction History